17 October - 6 November 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Biotin trial unsuccessful
Biotin didn't improve functional ability or walking speed in non relapsing progressive MS, according to a phase 3 trial that has been published in the Lancet. There was a small but not significant difference in people showing improvement in disability and walking speed compared to placebo. Previous, smaller trials had suggested the drug might be effective.
MS Trust link: Biotin (MD1003)
Carers fear burnout
Carers UK has warned that unpaid carers are struggling due to the pandemic and services such as day centres being closed. In a survey, around three in five reported their physical and mental health had been affected. Includes case study of a woman who cares for her partner with MS
MS Trust link: Carers
Measures of walking don't tell whole story
There is a gap between clinical measures of walking (such as the 6-Minute Walk Test) and real world measure (such as an activity monitor), according to Canadian research. Clinicians need to be more aware of the implications of day to day activity levels
Source: McGill University
MS Trust link: Walking difficulties
Gene and infection combination increases MS risk
People who have a variant of the HLA-DR15 gene, who are also infected with the Epstein-Barr virus (EBV) and have a symptomatic course of glandular fever (which is caused by EBV) have a 15-fold risk of MS, according to Swiss research. The gut bacterium Akkermansia muciniphila is also implicated as levels are higher in people with MS.
Source: Science Daily
MS Trust link: Epstein-Barr virus (EBV)
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.